Congress ordered food traceability in 2011. Enforcement begins in 2028. FDA's own math says the final delay costs more than it saves.

The finding, in one paragraph: when contaminated lettuce or onions or cucumbers start putting people in hospitals, the question that decides how many more get sick is how fast investigators can trace the food backward through the supply chain — and the national system Congress ordered built for that purpose in January 2011 will not be enforceable until July 2028.▸ Each stage of the seventeen-year arc is documented in a public text: the statute's two-year deadline, the court order it took to get a proposal nine years later, the 2022 final rule, the industry's request for more time, the agency's 30-month extension — and, most unusual, the agency's own cost-benefit analysis of that extension, which concludes, in its primary estimates, that the delay forgoes more in outbreak-prevention value than it saves in compliance costs. Congress enacted the delay anyway, as a one-paragraph rider in a stopgap funding law.

Five documents, read directly.▸ The mandate is FSMA § 204(d) (P.L. 111-353, January 4, 2011): "not later than 2 years after the date of enactment... the Secretary shall publish a notice of proposed rulemaking" for high-risk-food recordkeeping. The rule is FDA's Requirements for Additional Traceability Records for Certain Foods (87 FR 70910, November 21, 2022). The extension is FDA's compliance-date proposal (90 FR 38085, August 7, 2025) — including its regulatory impact analysis of the delay itself. The lock is Section 780 of P.L. 119-37 (November 2025), read verbatim: "No funds appropriated by this Act may be used to administer or enforce" the rule "prior to July 20, 2028." The enforcement history behind the proposal deadline is the Center for Food Safety v. FDA consent decree.

The rule the wait produced is genuinely new infrastructure: the first national farm-to-retail traceability standard, requiring covered entities to keep and share lot-level records for the foods on FDA's risk-based Food Traceability List — leafy greens, fresh-cut produce, soft cheeses, shell eggs, the recurring vehicles of American outbreaks.▸ Its purpose, in the agency's words, is to "rapidly and efficiently trace the movement" of implicated food and "identify and remove contaminated foods from the marketplace." The industry's objection, recorded in the extension proposal, is also real: many required data elements "are not routinely maintained or shared throughout supply chains," and the systems are not interoperable. That is not an argument the rule is wrong; it is a description of the gap the rule exists to close.

Regulatory impact analyses usually justify the action they accompany.▸ This one doesn't. FDA's primary estimates price the 30-month delay at −$1,348 million in forgone benefits (present value, 20 years, 3 percent) against $797 million in compliance-cost savings — a net loss of roughly $550 million, with the loss reaching $3.9 billion at the unfavorable end of the range. The "benefits" being forgone are not abstractions: they are the analysis's monetized value of illnesses not prevented and recalls not narrowed during the thirty months the tracing system sits unenforced.

Three texts, three positions, one government.▸ The statute commands speed — a two-year proposal deadline, in a section titled "rapidly and effectively identify recipients of a food." The agency missed it by more than seven years, moved only under a consent decree, and then, with the finish line set, proposed the delay while publishing arithmetic showing the delay to be value-destroying. And Congress — which wrote the two-year deadline in 2011 — wrote the enforcement bar in 2025, in an appropriations rider that also orders FDA to meet quarterly with regulated industry to find "additional flexibilities" in the rule's core lot-tracking requirement. The 2011 Congress legislated urgency; the 2025 Congress legislated delay; FDA's economists, alone among the participants, put numbers on the difference and were overruled by the agency's own front office and the appropriators in the same season. Nothing here is hidden: the mandate, the miss, the math, and the rider are all public texts. What is absent is any document arguing the delay passes a cost-benefit test — including the delay's own.

July 20, 2028 is now the operative date, and the rider's quarterly industry consultations create pressure toward "flexibilities" in lot-level tracking before then — each one measurable against the 2022 rule's text.▸ Outbreaks will not wait: every multistate trace between now and 2028 runs on the pre-rule system, and each becomes a data point on what the delay costs, priced in advance by the agency's own table at roughly $91 million a year. The FY2027 appropriations cycle decides whether Section 780's language reappears.

All texts quoted are read directly from govinfo (the statute, the extension proposal and its RIA, the appropriations rider). FDA's "negative benefits" notation for the delay's forgone value is reported as published; primary estimates at the 3 percent discount rate. The consent-decree history is per the Center for Food Safety litigation record.